Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

NCT01491958 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: atorvastatin
DRUG: Tacrolimus
DRUG: methotrexate

Sponsor

Ohio State University Comprehensive Cancer Center